References
- Plummer M, de Martel C, Vignat J, et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609–e616.
- Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–3044.
- Zapatka M, Borozan I, Brewer DS, et al. The landscape of viral associations in human cancers. Nat Genet. 2020;52(3):320–330.
- Bouvard V, Baan R, Straif K, et al. A review of human carcinogens – part B: biological agents. Lancet Oncol. 2009;10(4):321–322.
- Muñoz N, Castellsagué X, de González AB, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24:S1–S10.
- Bialecki ES, Di Bisceglie AM. Clinical presentation and natural course of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2005;17(5):485–489.
- Hermine O, Lefrère F, Bronowicki J-P, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347(2):89–94.
- Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res. 2004;10(3):803–821.
- Hausen HZ, Schulte-Holthausen H, Klein G, et al. Epstein–Barr virus in Burkitt’s lymphoma and nasopharyngeal carcinoma: EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 1970;228(5276):1056–1058.
- Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet. 1964;1(7335):702–703.
- Zhang E, Cotton VE, Hidalgo-Bravo A, et al. HHV-8-unrelated primary effusion-like lymphoma associated with clonal loss of inherited chromosomally-integrated human herpesvirus-6A from the telomere of chromosome 19q. Sci Rep. 2016;6:22730.
- Poiesz BJ, Poiesz MJ, Choi D. The human T-cell lymphoma/leukemia viruses. Cancer Invest. 2003;21(2):253–277.
- Moustafa A, Xie C, Kirkness E, et al. The blood DNA virome in 8,000 humans. PLoS Pathog. 2017;13(3):e1006292.
- Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390.
- Virgilio L, Lazzeri C, Bichi R, et al. Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci U S A. 1998;95(7):3885–3889.
- Patil P, Cieslak A, Bernhart SH, et al. Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia. Genes Chromosomes Cancer. 2020;59(4):261–267.
- Kojima K, Hara M, Sawada T, et al. Human T-lymphotropic virus type I provirus and T-cell prolymphocytic leukemia. Leuk Lymphoma. 2000;38(3–4):381–386.
- Lan K, Murakami M, Choudhuri T, et al. Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro. J Clin Virol. 2008;43(3):260–265.
- Schrader A, Crispatzu G, Oberbeck S, et al. Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL. Nat Commun. 2018;9(1):697.
- Wood DE, Lu J, Langmead B. Improved metagenomic analysis with kraken 2. Genome Biol. 2019;20(1):257.
- Wala JA, Bandopadhayay P, Greenwald NF, et al. SvABA: genome-wide detection of structural variants and indels by local assembly. Genome Res. 2018;28(4):581–591.
- Kepler GM, Banks HT, Davidian M, et al. A model for HCMV infection in immunosuppressed patients. Math Comput Model. 2009;49(7–8):1653–1663.
- Herbein G, Kumar A. The oncogenic potential of human cytomegalovirus and breast cancer. Front Oncol. 2014;4:230.
- Herbein G. The human cytomegalovirus, from oncomodulation to oncogenesis. Viruses. 2018;10(8):408.
- Krug LT, Pellett PE. Roseolovirus molecular biology: recent advances. Curr Opin Virol. 2014;9:170–177.
- Ogata M. Human herpesvirus 6 in hematological malignancies. J Clin Exp Hematop. 2009;49(2):57–67.
- Wingard JR. Viral infections in leukemia and bone marrow transplant patients. Leuk Lymphoma. 1993;11(Suppl. 2):115–125.
- Maura F, Rustad EH, Boyle EM, et al. Reconstructing the evolutionary history of multiple myeloma. Best Pract Res Clin Haematol. 2020;33(1):101145.
- Mundo L, Del Porro L, Granai M, et al. Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas. Mod Pathol. 2020;33(12):2407–2421.